More

    India’s Wait for COVAXIN WHO Approval to End Soon

    COVAXIN , WHO approval has been the most talked about topic in recent times, and the anxiety levels are up, but what is important to understand is that the process for EUL is taking the normal course with the Bharat Biotech promptly submitting all the information WHO is asking on a rolling basis.

    WHO chief Tedros Adhanom Ghebreyesus today discussed in detail the issue of the emergency use listing of Bharat Biotech’s Covid vaccine Covaxin and resumption of supplies of the Serum Institute of India-manufactured AstraZeneca vaccine to the COVAX facility among other topics during a telephonic conversation with Health Minister Mansukh Mandaviya.

    WHO Chief Tedros Discussed in detail about COVAXIN approval with Health Minister Mandaviya

    “Had a call with @mansukhmandviya, India’s Health Minister, to discuss #India’s ongoing #COVID19 vaccination programme; the need for a global pandemic agreement; digital health; & traditional medicine. We welcome India’s support to strengthen WHO, incl. via flexible, sustainable financing,” Ghebreyesus tweeted on Tuesday.

    The WHO Director-General said that he also discussed with Mandaviya vaccine equity issues: “the resumption of SII/AstraZeneca vaccine supplies to #COVAX; the Covaxin Emergency Use Listing process; and technology and licence sharing through C-TAP.”

    Covid Technology Access Pool (C-TAP) was launched in May last year for facilitating timely, equitable and affordable access of Covid health products by boosting their supply.

    Mandaviya had also tweeted that he had a “detailed interaction” with the WHO chief, accompanied by other senior officials of the global health agency “on various issues related to health, including pandemic management and WHO reforms.

    “DG WHO lauded the mammoth efforts undertaken by the Indian government for #COVID19 vaccination,” Mandaviya tweeted.

    The cumulative number of Covid vaccine doses administered in India crossed 99 crore on Tuesday and the country is close to administering 100 crore doses. According to official figures, around 74.45 per cent of India’s eligible adult population has been administered at least one dose of the Covid vaccine and around 30.63 per cent have received both doses.

    “We are aware that many people are waiting for WHO’s recommendation for Covaxin to be included in the #COVID19 Emergency Use Listing, but we cannot cut corners – before recommending a product for emergency use, we must evaluate it thoroughly to make sure it is safe and effective,” the global health organisation had said in a tweet.

    WHO chief Tedros Adhanom Ghebreyesus discussed the issue of the emergency use listing of Bharat Biotech’s Covid vaccine Covaxin and resumption of supplies of the Serum Institute of India-manufactured AstraZeneca vaccine to the COVAX facility among other topics during a telephonic conversation with Health Minister Mansukh Mandaviya.

    “Had a call with @mansukhmandviya, India’s Health Minister, to discuss #India’s ongoing #COVID19 vaccination programme; the need for a global pandemic agreement; digital health; & traditional medicine. We welcome India’s support to strengthen WHO, incl. via flexible, sustainable financing,” Ghebreyesus tweeted on Tuesday.

    The WHO Director-General said that he also discussed with Mandaviya vaccine equity issues: “the resumption of SII/AstraZeneca vaccine supplies to #COVAX; the Covaxin Emergency Use Listing process; and technology and licence sharing through C-TAP.”

    Mandaviya had also tweeted that he had a “detailed interaction” with the WHO chief, accompanied by other senior officials of the global health agency “on various issues related to health, including pandemic management and WHO reforms.

    “DG WHO lauded the mammoth efforts undertaken by the Indian government for #COVID19 vaccination,” Mandaviya tweeted.

    The cumulative number of Covid vaccine doses administered in India crossed 99 crore on Tuesday and the country is close to administering 100 crore doses. According to official figures, around 74.45 per cent of India’s eligible adult population has been administered at least one dose of the Covid vaccine and around 30.63 per cent have received both doses.

    “We are aware that many people are waiting for WHO’s recommendation for Covaxin to be included in the #COVID19 Emergency Use Listing, but we cannot cut corners – before recommending a product for emergency use, we must evaluate it thoroughly to make sure it is safe and effective,” the global health organisation had said in a tweet.

    “Bharat Biotech – the manufacturer of Covaxin – has been submitting data to WHO on a rolling basis and WHO experts have reviewed these data

    Share

    Latest Updates

    Related Articles

    India Vs South Africa T201 Match: It’s Housefull

    India Vs South Africa Guwahati match tickets are fully sold out. According to match...

    Bayern Munich snap their losing streak, thanks to Musiala strikes

    In a 4-0 victory over Bayer Leverkusen on Friday, Jamal Musiala scored once and...

    Adipurush First Look of Prabhas Character is Visually Stunning

    Prabhas Adipurush first look was unveiled on Friday morning. Taking to his Instagram account,...

    Novak Djokovic returns to ATP tour with a big, effortless win at Tel Aviv

    Top-seeded Novak Djokovic was at his very best in his first ATP match in...